Modern therapies for pelvic floor dysfunction in women due to surgical menopause

Aim. To compare the effectiveness of the kGoal vaginal trainer combined with the intimate non-hormonal phytocomplex with hyaluronic acid, Estrogial, for the non-surgical treatment of the early stages of pelvic prolapse in women with surgical menopause. Materials and methods. We examined 65 patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatiana Y. Pestrikova, Anastasia V. Kotelnikova, Elena G. Veselkova, Elena A. Yurasova, Igor V. Yurasov, Natalia V. Strelnikova
Format: Article
Language:Russian
Published: IP Berlin A.V. 2025-01-01
Series:Гинекология
Subjects:
Online Access:https://gynecology.orscience.ru/2079-5831/article/viewFile/646865/191870
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850174159338864640
author Tatiana Y. Pestrikova
Anastasia V. Kotelnikova
Elena G. Veselkova
Elena A. Yurasova
Igor V. Yurasov
Natalia V. Strelnikova
author_facet Tatiana Y. Pestrikova
Anastasia V. Kotelnikova
Elena G. Veselkova
Elena A. Yurasova
Igor V. Yurasov
Natalia V. Strelnikova
author_sort Tatiana Y. Pestrikova
collection DOAJ
description Aim. To compare the effectiveness of the kGoal vaginal trainer combined with the intimate non-hormonal phytocomplex with hyaluronic acid, Estrogial, for the non-surgical treatment of the early stages of pelvic prolapse in women with surgical menopause. Materials and methods. We examined 65 patients who came for an outpatient consultation 6–12 months after surgery (extirpation and/or amputation of the uterus with appendages). All study subjects were diagnosed with POP-Q grade 1 pelvic organ prolapse at the time of the first visit. In addition, some patients complained of urge urinary incontinence and various symptoms typical for the genitourinary menopausal syndrome. The mean age of study patients was 48.7±6.5 years (99% confidence interval 46.62–50.78); the mean age of surgical menopause was 50.1±2.8 years (99% confidence interval 49.21–50.99); the duration of surgical menopause was 6 months to 1 year. Symptoms in patients at outpatient Visit 1 included dysuria in 29 (44.62%), stress urinary incontinence in 23 (35.39%), sexual dysfunction in 26 (40.00%), sensations of vagina dryness in 45 (69.23%), splashing sounds in the vagina during sexual intercourse or sports in 18 (27.69%), loss of vagina sensitivity in 12 (18.46%). The treatment effectiveness was assessed in 3, 6, and 9 months. Results. After 9 months of treatment, dysuria persisted in 2 (3.33%) patients. Stress urinary incontinence persisted in 5 (8.33%) patients and sexual dysfunction in 3 (5.00%) patients. Five (8.33%) patients still reported splashing sounds in the vagina during sexual intercourse or sports. The sensation of vagina dryness and loss of vagina sensitivity after treatment were not reported in any of the patients. The significance of the association of the surgical menopause sequelae with individual clinical signs of pelvic organ prolapse was relatively high and very high (p0.05). Conclusion. The study on kGoal vaginal trainer combined with the local non-hormonal phytocomplex with hyaluronic acid in patients with surgical menopause showed statistically significant, good, and satisfactory clinical efficacy, reducing the clinical manifestations of pelvic organ prolapse and the severity of the symptoms of surgical menopause-related genitourinary menopausal syndrome.
format Article
id doaj-art-ff17c4f874204dec9be07402fb63f59f
institution OA Journals
issn 2079-5696
2079-5831
language Russian
publishDate 2025-01-01
publisher IP Berlin A.V.
record_format Article
series Гинекология
spelling doaj-art-ff17c4f874204dec9be07402fb63f59f2025-08-20T02:19:43ZrusIP Berlin A.V.Гинекология2079-56962079-58312025-01-01271495310.26442/20795696.2025.1.20314479615Modern therapies for pelvic floor dysfunction in women due to surgical menopauseTatiana Y. Pestrikova0https://orcid.org/0000-0003-0219-3400Anastasia V. Kotelnikova1https://orcid.org/0000-0002-8143-5932Elena G. Veselkova2https://orcid.org/0009-0007-4339-6665Elena A. Yurasova3https://orcid.org/0000-0002-7771-3549Igor V. Yurasov4https://orcid.org/0000-0001-6397-7052Natalia V. Strelnikova5https://orcid.org/0000-0002-1749-1323Far Eastern State Medical UniversityFar Eastern State Medical UniversityFar Eastern State Medical UniversityFar Eastern State Medical UniversityFar Eastern State Medical UniversityFar Eastern State Medical UniversityAim. To compare the effectiveness of the kGoal vaginal trainer combined with the intimate non-hormonal phytocomplex with hyaluronic acid, Estrogial, for the non-surgical treatment of the early stages of pelvic prolapse in women with surgical menopause. Materials and methods. We examined 65 patients who came for an outpatient consultation 6–12 months after surgery (extirpation and/or amputation of the uterus with appendages). All study subjects were diagnosed with POP-Q grade 1 pelvic organ prolapse at the time of the first visit. In addition, some patients complained of urge urinary incontinence and various symptoms typical for the genitourinary menopausal syndrome. The mean age of study patients was 48.7±6.5 years (99% confidence interval 46.62–50.78); the mean age of surgical menopause was 50.1±2.8 years (99% confidence interval 49.21–50.99); the duration of surgical menopause was 6 months to 1 year. Symptoms in patients at outpatient Visit 1 included dysuria in 29 (44.62%), stress urinary incontinence in 23 (35.39%), sexual dysfunction in 26 (40.00%), sensations of vagina dryness in 45 (69.23%), splashing sounds in the vagina during sexual intercourse or sports in 18 (27.69%), loss of vagina sensitivity in 12 (18.46%). The treatment effectiveness was assessed in 3, 6, and 9 months. Results. After 9 months of treatment, dysuria persisted in 2 (3.33%) patients. Stress urinary incontinence persisted in 5 (8.33%) patients and sexual dysfunction in 3 (5.00%) patients. Five (8.33%) patients still reported splashing sounds in the vagina during sexual intercourse or sports. The sensation of vagina dryness and loss of vagina sensitivity after treatment were not reported in any of the patients. The significance of the association of the surgical menopause sequelae with individual clinical signs of pelvic organ prolapse was relatively high and very high (p0.05). Conclusion. The study on kGoal vaginal trainer combined with the local non-hormonal phytocomplex with hyaluronic acid in patients with surgical menopause showed statistically significant, good, and satisfactory clinical efficacy, reducing the clinical manifestations of pelvic organ prolapse and the severity of the symptoms of surgical menopause-related genitourinary menopausal syndrome.https://gynecology.orscience.ru/2079-5831/article/viewFile/646865/191870surgical menopausepelvic organ prolapsekgoal vaginal trainernon-hormonal phytocomplex with hyaluronic acid
spellingShingle Tatiana Y. Pestrikova
Anastasia V. Kotelnikova
Elena G. Veselkova
Elena A. Yurasova
Igor V. Yurasov
Natalia V. Strelnikova
Modern therapies for pelvic floor dysfunction in women due to surgical menopause
Гинекология
surgical menopause
pelvic organ prolapse
kgoal vaginal trainer
non-hormonal phytocomplex with hyaluronic acid
title Modern therapies for pelvic floor dysfunction in women due to surgical menopause
title_full Modern therapies for pelvic floor dysfunction in women due to surgical menopause
title_fullStr Modern therapies for pelvic floor dysfunction in women due to surgical menopause
title_full_unstemmed Modern therapies for pelvic floor dysfunction in women due to surgical menopause
title_short Modern therapies for pelvic floor dysfunction in women due to surgical menopause
title_sort modern therapies for pelvic floor dysfunction in women due to surgical menopause
topic surgical menopause
pelvic organ prolapse
kgoal vaginal trainer
non-hormonal phytocomplex with hyaluronic acid
url https://gynecology.orscience.ru/2079-5831/article/viewFile/646865/191870
work_keys_str_mv AT tatianaypestrikova moderntherapiesforpelvicfloordysfunctioninwomenduetosurgicalmenopause
AT anastasiavkotelnikova moderntherapiesforpelvicfloordysfunctioninwomenduetosurgicalmenopause
AT elenagveselkova moderntherapiesforpelvicfloordysfunctioninwomenduetosurgicalmenopause
AT elenaayurasova moderntherapiesforpelvicfloordysfunctioninwomenduetosurgicalmenopause
AT igorvyurasov moderntherapiesforpelvicfloordysfunctioninwomenduetosurgicalmenopause
AT nataliavstrelnikova moderntherapiesforpelvicfloordysfunctioninwomenduetosurgicalmenopause